The Orthopaedic bone cement and casting material market is expected to reach approximately USD 3,237.7 million in 2025 and expand to around USD 5,445.9 million by 2035, reflecting a compound annual growth rate (CAGR) of 5.3% over the forecast period.
The orthopaedic bone cement and casting material market is projected to be steady between 2025 and 2035, owing to increasing cases of osteoarthritis, osteoporosis, and traumatic injuries coupled with a gradual increase in the aging population worldwide.
Orthopaedic bone cement are used for fixation of the components in joint implants and for filling of bone defects in operations such as total hip arthroplasty and total knee arthroplasty, whereas casting material is important in fracture management without surgery.
Additionally, orthopedic surgeries are also on the rise in emerging economies, and advancements in polymer science to produce antibiotic-impregnated cements and subdual fiberglass casting options further drive the growth of the global orthopedic casting market. The move toward outpatient surgical procedures and minimally invasive treatment is also driving demand for quick-setting, biocompatible materials.
Key Market Metrics
| Metric | Value (USD Million) |
|---|---|
| Industry Size (2025E) | USD 3,237.7 Million |
| Industry Value (2035F) | USD 5,445.9 Million |
| CAGR (2025 to 2035) | 5.3% |
Historically, this market focused almost exclusively on traditional plaster of Paris and basic polymethylmethacrylate (PMMA) formulations. The market was initially characterized by basic, affordable products for fracture stabilization and implant fixation, before slowly transitioning toward more advanced, high-performance products.
The growing surgical volumes for joint replacements and trauma care propelled the development of antibiotic-loaded bone cements, which help in controlling infections in revision surgeries. At the same time, improvements in casting materials contributed to the development of fiberglass and thermoplastics with superior tensile strength, increased patient comfort and radiolucency.
A transition to a more minimally invasive approach and outpatient-based care changed product requirements for surgical materials further towards quick-setting, biocompatible and ergonomic materials. These trends collectively signify a move from utility to precision-driven orthopaedic solutions.
Explore FMI!
Book a free demo
The North America region is the leader in the global orthopedic bone cement and casting material market, owing to the increasing prevalence of osteoarthritis, osteoporosis, and trauma injuries. The US is a key contributor owing to its advanced healthcare infrastructure, use of novel biomaterials with high order volume involvement in joint replacement surgeries.
Aging demographics and increasing sports-related injuries also support demand. Antibiotic-loaded cements and fiberglass casting alternatives are also gaining prominence in the region owing to faster recovery and better control of infections.
Robust geographical existence comprises vital competitors such as Stryker and Zimmer Biomet, contributing to the overall competitiveness of the market. Over the forecast period, reimbursement policies, outpatient surgical trends, and a focus on minimally invasive techniques will drive innovation and sustained market growth in both the USA and Canadian markets.
The orthopedic bone cement and casting material market in the European region is led by Germany, the UK and France. The geographic region is enriched with an aging population, increasing joint arthroplasty surface procedures, and strong clinical orthopedic biomaterial study.
Antibiotic-loaded and high-viscosity bone cements are the most commonly used products, especially in revision surgeries. Furthermore, prominent industry participants, such as Heraeus and Smith & Nephew, aid in facilitating technological development and product variation.
With stringent biocompatibility and safety requirements embedded in European regulatory standards, the pressure on manufacturers to comply with quality guidelines and regulations is immense. Outpatient care and rehabilitation centers continue to rise in Western Europe, further positioning the region as a leader in innovations in orthopedic materials and driving demand for cutting-edge patient-friendly casting solutions.
Asia-Pacific is expected to experience the fastest growth in the orthopedic bone cement and casting materials market, owing to a rise in trauma cases, a boosting geriatric population, and increased healthcare access in the region. China, Japan, and India are leading these metrics with a rise in orthopedic procedures and increasing awareness regarding joint replacement surgeries.
Urbanization, enhanced surgical capacities and government healthcare reforms all have driven the need for high-performance yet cost-effective materials. Although affordability is a concern in rural areas, urban hospitals are already using more advanced options, such as antibiotic-loaded cements and thermoplastic casting systems.
Japan plays precision and quality, while India markets affordability and access. With increasing local manufacturing and foreign investments, the region is becoming an important growth engine for the global orthopedic materials market.
Infection and Antibiotic Resistance Risks
One of the main risks to orthopedic bone cement is, in fact, the burgeoning of antibiotic resistance. While antibiotic-loaded bone cements have become a somewhatstandard part of the management of postoperative infections, especially in high-risk procedures, such as joint replacement or trauma surgery, their overuse or wrong choice in many cases leads to the selection of antibiotic-resistant bacterial strains.
Hence, the long-term usage of the cements is limited, leading to increased chances of complications and costs associated with implant-associated infections in an otherwise very difficult to manage environment. Many of the MDROs have also forced healthcare providers to reevaluate the process of prophylaxis.
This is now a double-edged sword for manufacturers who need to explore new drug delivery systems or develop some nonantibiotic antimicrobial technologies while adhering to the rigorous regulatory space of antibiotic use in orthopedic biomaterials.
Shift Toward Outpatient and Minimally Invasive Procedures
The increasing preference for living-room orthopedic surgery as well as minimally invasive procedures is one of the biggest opportunities for the orthopedic bone cement and casting material in the market. However, ASC has only recently begun performing joint replacement, fracture repair and trauma care procedures owing to lower cost, fewer inpatient days, and quicker turnover time of patients (6).
This transition advances the need for fast-setting, high-performance bone cements that ensure rapid fixation and allow early mobilization. Similarly, lightweight and water-resistant casting materials like fiberglass and thermoplastics are favored for comfort, application, and radiolucency. Manufacturers of efficient and patient-friendly materials will be well suited to capitalize on this emerging market as health systems continue to look for an optimization of its resources in exchanges for improved patient outcomes.
Antibiotic-Loaded Bone Cement
One of the most significant breakthroughs is a bone cement that contains antibiotics. This represents a revolutionary conceptual shift in the orthopedic industries of bone cements and casting materials, especially in revision arthroplasty and trauma operations. Antibacterial agents such as gentamicin or vancomycin release slowly in the surgical field to curb the colonization of implanted devices by bacteria.
In this antimicrobial targeting, the likelihood of acquiring postoperative infections is significantly decreased, especially in high-risk patients, and thereby improving the results and lowering the rate of failed orthopedic implants. Orthopedic surgeons recommend increasing antibioticification to enhance surgical outcomes and reduce both length of hospital stay and subsequent rates of reoperation.
In addition to this, the concern over hospital-acquired infection and antibiotic resistance continues to grow, thus increasing demand for such novel cements in developed and emerging healthcare markets.
Fiberglass and Thermoplastic Casting Materials
Replacing old plaster of Paris with new fiber-glass and thermoplastic casting materials for an orthopedic bone cement and casting materials market is a trend that is on the rise. Unlike the conventional plaster of Paris casts, these modern alternatives are quite a number of benefits in clinical practice; their weights are relatively less, they possess radiolucency, and they also have waterproof properties, all of which make them very comfortable during application on both pediatric and adult fractures.
This also forms the bases upon which these properties were built such as good radiolucency, thus allowing for very clear imaging without having to take cast, and water resistance which helps improve hygiene and the ability of the patient to be mobile during recovery.
Casts made from thermoplastics remain malleable and can be remolded based on the evolving condition of the patient for options in long-term treatment adaptations. A growing number of patients prefer comfort while at the same time increasing outpatient fracture care and sport injuries, so that the use of these materials in hospitals, clinics, and rehabilitation centers across the globe is expected to widen.
Between 2020 and 2024, the orthopaedic bone cement and casting material market observed consistent recovery due to the prevention of supply chain disruptions and reduction of elective surgery delays. The market in general however, continued to grow continuously, driven by the growing prevalence of osteoporosis, osteoarthritis and orthopedic trauma.
Expansion of the market was attributed to rise in adoption of joint replacement surgeries and advancements in antibiotic-loaded cement formulations. The move towards fiberglass and thermoplastic casting materials was also accelerated through the greater comfort afforded to the patient and their radiolucent behavior. But the high cost of products, regulatory issues and limited access in rural areas limited wider adoption in markets where consumers are price sensitive.
And the market promise to grow significantly from 2025 to 2035, propelled by innovation in biomaterials, rapid- setting cements, or even custom casting. Increasing demand for outpatient as well as minimally invasive orthopedic procedures will fuel the product adoption.
Such initiatives are likely to expedite product development through increased R&D investment and collaboration between device manufacturers and healthcare providers. With improved reimbursement frameworks and focus on advanced care for emerging economies, the market is expected to grow further and become global.
| Market Aspect | 2020 to 2024 |
|---|---|
| Regulatory Landscape | Emphasis on biocompatibility and infection control. Regulatory agencies required rigorous clinical validation, especially for antibiotic-loaded and novel cement blends. |
| Technological Advancements | Focus on high-viscosity cements, improved mixing systems, and the transition from plaster to fiberglass and thermoplastic materials for better performance and comfort. |
| Consumer Demand | Driven by rising orthopedic procedures and patient preference for lightweight, water-resistant casts and materials supporting quicker recovery. |
| Market Growth Drivers | Growth fueled by aging populations, trauma cases, and expanding surgical volumes. Adoption supported by evolving hospital infrastructure and biomaterial innovations. |
| Sustainability | Limited focus on environmental impact. Most manufacturers prioritized performance and sterility over eco-consciousness. |
| Supply Chain Dynamics | Reliance on global suppliers for raw materials and prefilled cement systems. COVID-19-related disruptions impacted availability and elective procedure volumes. |
| Market Aspect | 2025 to 2035 |
|---|---|
| Regulatory Landscape | Shift toward faster approvals for innovative formulations such as bioactive cements and smart casting materials. Greater global harmonization may streamline product clearances. |
| Technological Advancements | Emergence of customizable, resorbable bone cements and 3D-printed casting systems. Advancements in drug-eluting and smart-response materials for targeted therapy applications. |
| Consumer Demand | Increased demand for personalized orthopedic solutions, especially in outpatient settings. Patients favor fast-setting, minimally invasive, and aesthetic post-op materials. |
| Market Growth Drivers | Accelerated by outpatient surgical growth, sports injury recovery, and innovations in delivery systems. Greater access in emerging markets expands the addressable patient base. |
| Sustainability | Rising emphasis on biodegradable materials and sustainable casting alternatives. ESG integration and carbon footprint reduction become key aspects of product development. |
| Supply Chain Dynamics | Transition toward regional manufacturing hubs, local sourcing of casting materials, and improved logistics networks to mitigate delays and strengthen supply chain resilience. |
Market Outlook
The United States constitutes the largest orthopedic bone cement and casting materials market, with a high volume of joint replacement procedures and a strong healthcare infrastructure. An aging population, growing incidence of osteoarthritis and rising cases of sports injuries are driving up demand.
Technologies as simple as antibiotic-loaded bone cements and precision delivery systems to more complex mobile solutions have become ubiquitous in hospital and surgical center right across the globe. Key players such as Stryker and Zimmer Biomet have a strong footing against each other.
Furthermore, supportive reimbursement policies and early uptake of minimally invasive orthopedic surgeries drive the market growth. There is also increasing adoption of outpatient procedures, which is another driver for the demand for quick-setting and high-strength casting solutions.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| United States | 2.9% |
Market Outlook
Germany commands the largest European orthopedic bone cement and casting material market share owing to its superior healthcare infrastructure, large number of procedures performed, and a strong clinical interest in orthopedic care in the country. Joint arthroplasties are performed at a high rate driven in part by the aging population of the country, resulting in continued need for bone cements such as the Heraeus class of bone cements PALACOS®.
In addition, the German market rewards evidence-based, high-performance biomaterials, promoting the innovation of antibiotic-loaded and high-viscosity cements. Reimbursement support and hospital procurement standards promote CE-marked high-quality materials. Premium casting products arm orthopedic clinics and rehabilitation centers as the field reflects the country’s move towards durable, patient-centric offerings for post-operative and trauma care.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Germany | 3.7% |
Market Outlook
In the UK, orthopedic bone cement and casting material market is driven by factors such as NHS funded joint replacements, high incidence of orthopedic trauma and increasing preference for minimally invasive procedures. The rise in the aging population along with the increasing obesity crisis has led to greater incidences of osteoarthritis, requiring a greater number of hip and knee replacements.
In the local market, companies such as Smith & Nephew are important, providing innovative casting systems and biomaterials. Although cost constraints in public healthcare settings may play a role in purchasing decisions, quality and infection control are paramount, particularly in revision surgeries. There is also a significant trend towards outpatient care and early mobility protocols leading to a demand for rapid application casting and high strength cement solutions.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| United Kingdom | 2.8% |
Market Outlook
The orthopedic bone cement and casting material market in Japan is driven by the rapidly aging population, high standards of care, and government-assisted healthcare initiatives. Bone cement reserves a steady demand due to the increasing replacements of hip and knee replacing the degenerating joints owing to age. Within the country, a major focus on product quality, biocompatibility, and infection control is observed and the use of antibiotic-loaded and high-viscosity cements is prevalent.
In Japan, hospitals require precision casting and immobilisation materials for trauma and postoperative care as well. Testing standards are stringent, and local manufacturers work closely with international players to ensure compliance. Moreover, the shift towards minimally invasive surgical approaches and early rehabilitation protocols fuels the ascension of light-weight, user-friendly casting materials.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| Japan | 5.3% |
Market Outlook
The Indian orthopedic bone cement and casting material market is increasing rapidly as a result of rising number of fractures, osteoarthritis cases, and trauma from road accidents. This is further driven by an exponentially growing, aging population, and improve knowledge of joint replacement surgeries among consumers that drives the need in this segment for, affordable and effective bone cements. While cost remains a significant hurdle for rural areas, advanced materials adoption is increasing in urban centers.
The government schemes such as Ayushman Bharat are expanding access to orthopedic procedures which is creating a market for local and international manufacturers. An increasing interest towards the development of fast-setting, antibiotic-loaded bone cements is developed and used in infection-prone environments. And the demand for affordable yet durable casting materials is strong in tier-2 and tier-3 cities where outpatient trauma treatment is increasing.
Market Growth Factors
Market Forecast
| Country | CAGR (2025 to 2035) |
|---|---|
| India | 5.5% |
Bone Cement Dominated the Market Due to Its Critical Role in Joint Replacement and Trauma Surgeries.
Bone cement, usually composed of polymethyl methacrylate (PMMA), is crucial for implant-prosthesis fixation, allowing for better distribution of the transmitted loads on the bone. The key factors attributing to the demand for this market are increasing geriatric population, growing prevalence of osteoporosis and osteoarthritis, and rise in the adoption rate of minimally invasive joint replacement procedures.
The high volumes of surgeries performed and well-developed healthcare infrastructure in North America and Europe are the factors prompting the leading of these regions in the market. Technological innovations like antibiotic-impregnated cements, radiopaque formulations, and vacuum mixing systems enhance infection control and mechanical strength.
These will be bioactive bone cements, resorbable and patient-specific formulations that will be customized to the patient's bone density and activity level as part of a trend toward personalized orthopedic care.
Casting Materials Dominated the Market Owing to Their Extensive Use in Fracture Management.
fiberglass casting materials are one of the most widely used types of immobilization as they have begun to replace plaster of paris in the majority of cases as a result of their lower weight, their higher strength, their radiolucency, and increased comfort to patients. Fiberglass casts find widespread application in fracture management, post-operative immobilization, and orthopedic trauma, resulting in their preference across emergency departments, orthopedic clinics, and sports medicine.
The growth is attributed to the rising occurrence of sports injuries, road accidents, and fall-related fractures, especially amongst the geriatric populations. Color-customizable, water-resistant fiberglass systems have become an early-adoption choice in developed regions such as the USA, Germany, and Japan, while Asia-Pacific is enjoying rapid adoption in urban healthcare settings.
Products are being innovated with breathable, quick-drying synthetic materials, along with integrated padding systems to mitigate skin irritation. These digital cast design, 3D-printed casting frames and intelligent cast materials with healing and pressure-sensitive sensors will shape future demand.
Joint Arthroplasty Dominated the Market Due to The Growing Prevalence of Degenerative Joint Diseases.
Joint arthroplasty-especially total hip and knee replacements-represents the largest area of application of bone cement in which obtaining strong, enduring fixation between prosthesis and bone is of paramount importance for long-term outcomes. PMMA-based cements are still our mainstay, however antibiotic-loaded and high viscosity versions are becoming popular due to possible benefits in infection control and ease of use in complex revisions.
Increasing life expectancy, higher incidence of degenerative joint diseases, and improved surgical techniques are driving the joint replacement rates worldwide. North America and Western Europe remain the segment leaders, with Asia-Pacific and Latin America noted for strong procedural growth.
Conventional robot-assisted cementing and cementless hybrid systems are being performed by major orthopedic centers. Innovations foresight being the bioactive and injectable cements, real time intraoperative cement monitoring systems, and resorbable formulations are also avenues being utilized to encourage biologic ingrowth in younger and active patient populations.
Fracture Care and Trauma Dominated the Market Due to The High Incidence of Accidental Injuries.
Trauma is a huge part of the casting materials market, including acute orthopedic injuries, stress fractures, and post-surgical immobilization. Fiberglass and hybrid casting materials provide a good strength-to-weight ratio, moldability and a better fit in pediatric and geriatric care.
The burden of trauma is rising in developing countries with growing emergency medical systems. The Asia-Pacific and Middle East is a potential high-growth region and is expected to witness a surge in hospital investment in public healthcare, especially in orthopedic trauma management.
Product innovations include pre-formed splints, rapid-application casting tapes and reusable mold systems - all of which address reducing hospital waste. After that, future treatments are orientation by antimicrobial-coated cast materials, embedded therapeutic compression, and AI-powered cast-guided tools for personalized fracture alignment and connected orthopedic platforms for real-time assessment of healing.
Growth in the orthopaedic bone cement and casting materials market has been consistent and continues to remain in growth mode due to the increase in musculoskeletal disorders associated with osteoarthritis, osteoporosis and trauma. Increased incidence of fractures in the aging population, as well as in the increasing numbers of sports and accident-related fractures, contributes to the demand for more efficient orthopedic interventions.
The adoption of new bone cements and lightweight high-strength casting materials has also changed the way orthopedic treatment is evolving, with a clear trend towards minimally invasive surgical procedures. Competition in the market is characterized by orthopedic device manufacturers and their biomaterial technology developers and small specialized suppliers of casting products.
Their focus is to deliver highly advanced biocompatible materials for use in hospitals, ambulatory surgical centers, as well as outpatient clinics. Building and sustaining the competitive edge in such an evolving environment would also see innovation in antibiotic-loaded cements, customized delivery systems, and patient-focused casting solutions.
Market Share Analysis by Company
| Company Name | Estimated Market Share (%) |
|---|---|
| Stryker Corporation | 20-24% |
| Zimmer Biomet Holdings, Inc. | 16-20% |
| Heraeus Holding GmbH | 12-16% |
| DJO Global ( Enovis ) | 8-12% |
| Smith & Nephew plc | 5-9% |
| Other Companies (combined) | 20-30% |
| Company Name | Key Offerings/Activities |
|---|---|
| Stryker Corporation | Offers high-viscosity bone cements and vacuum mixing systems used in joint arthroplasty procedures. |
| Zimmer Biomet Holdings | Provides bone cement systems and cast materials used in hip, knee, and trauma surgeries. |
| Heraeus Holding GmbH | Specializes in PMMA-based bone cements with antibiotic formulations under the PALACOS® brand. |
| DJO Global ( Enovis ) | Supplies lightweight, rigid casting tapes and splinting materials for orthopedic immobilization. |
| Smith & Nephew plc | Offers advanced casting and bracing products along with injectable bone void fillers. |
Key Company Insights
Other Key Players (20-30% Combined) Other contributors to the orthopaedic bone cement and casting material market include:
These companies support the market through innovations in antibiotic-loaded formulations, biodegradable casting materials, and enhanced surgical workflows tailored to both high-volume and specialized orthopedic care.
The global orthopaedic bone cement and casting material industry is projected to witness CAGR of 5.3% between 2025 and 2035.
The global orthopaedic bone cement and casting material industry stood at USD 3,074.8 million in 2024.
The global orthopaedic bone cement and casting material industry is anticipated to reach USD 5,445.9 million by 2035 end.
China is expected to show a CAGR of 6.0% in the assessment period.
The key players operating in the global orthopaedic bone cement and casting material industry are Stryker Corporation, Zimmer Biomet Holdings, Heraeus Holding GmbH, DJO Global (Enovis), Smith & Nephew plc, Teknimed, Exactech, Inc., Orthofix Medical Inc., BSN Medical (Essity), Baxter International Inc. and Others.
Bone Cement, Casting Materials, Plaster, Fiberglass and Others.
Joint Arthroplasty, Trauma Cases, Sports Injury, Spine Surgeries and Others.
Hospitals, Ambulatory Surgical Centers and Orthopedic Clinics.
North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East & Africa.
Protein Diagnostics Market Share, Size and Forecast 2025 to 2035
CGRP Inhibitors Market Trends - Growth, Demand & Forecast 2025 to 2035
Indolent Systemic Mastocytosis treatment Market Insights: Size, Trends & Forecast 2025 to 2035
Intraoperative Fluorescence Imaging Market Report - Demand, Trends & Industry Forecast 2025 to 2035
Lung Cancer PCR Panel Market Trends, Growth, Demand & Forecast 2025 to 2035
Polymyxin Resistance Testing Market Trends – Innovations & Growth 2025 to 2035
Orthopaedic Bone Cement and Casting Material Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
